Viral Hepatitis
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2005; 11(23): 3504-3507
Published online Jun 21, 2005. doi: 10.3748/wjg.v11.i23.3504
Figure 1
Figure 1 Recognizing and catalytic sequences of DrzBS (A) and DrzBC (B) and their corresponding cleaving sites.
Figure 2
Figure 2 Dose-dependent inhibition of DNAzymes on the expression of HBsAg and HBeAg 48 h after administration of DrzBS or DrzBC.
Figure 3
Figure 3 Time-efficiency characteristics of DrzBS (A) and DrzBC (B) on the expressions of HBsAg and HBeAg.